Newomics Analysis: $12M Raised
What is Newomics?
Newomics develops a unified multiomics platform powered by multispray technology for enhanced mass spectrometry applications. Their products, including the UniESI system, M3 emitters, and MEA chips, are designed for high sensitivity and throughput in proteomics, metabolomics, and other applications. The company serves various sectors including clinical diagnostics and environmental monitoring.
Location
804 Heinz Ave, Berkeley, California 94710, United States
Employees
1-10
Founded
2011
Funding Status
Series B
Product Features & Capabilities
- UniESI system
- M3 emitters
- MEA chips
- Native MS solutions
- Metabolomics applications
Use Cases
Conduct native mass spectrometry for proteomics; Perform metabolomics analysis in clinical settings; Enable single-cell omics research; Facilitate drug development processes; Support food and environmental monitoring
Other Considerations
ISO 9001:2015 certified; Partnerships with major mass spectrometer manufacturers; Recognized for high sensitivity and throughput in mass spectrometry applications
See something that needs updating? Suggest edits to this profile.